Contributor Network for Lifesciences insudtry

EUROPE

APAC

CANADA

Antibodies: The Building Blocks of Cures

John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma

The Future of Life Sciences Industry

Matthew (Matt) Hewitt, Executive Director, Scientific Solutions C and GT, Charles River

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Mark Mintz, Chief Information Officer at Charles River Laboratories

Re-imagining Learning in a Post-Pandemic World

Sebastian Teo, Head of Learning & Talent Management, Linde

How Charles River Labs is Re-Imaging Digital Transformation with Design Thinking

Erin Howard, Executive Director of Product, Service, and Experience Design, Charles River Labs

How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

Li Chen, Vp & General Manager, West Pharmaceutical

The Science Behind Addiction and Why it Matters to Employers

Justin Yang, M.D. MPH, Medical Director, Quit Genius

Antibodies: The Building Blocks of Cures

John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma
The Future of Life Sciences Industry

Matthew (Matt) Hewitt, Executive Director, Scientific Solutions C and GT, Charles River
Accelerating Digital Transformation through an Agile, Customer-centric Approach

Mark Mintz, Chief Information Officer at Charles River Laboratories
Re-imagining Learning in a Post-Pandemic World

Sebastian Teo, Head of Learning & Talent Management, Linde
How Charles River Labs is Re-Imaging Digital Transformation with Design Thinking

Erin Howard, Executive Director of Product, Service, and Experience Design, Charles River Labs
How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

Li Chen, Vp & General Manager, West Pharmaceutical
The Science Behind Addiction and Why it Matters to Employers

Justin Yang, M.D. MPH, Medical Director, Quit Genius

Put your Frontline Teams in the Driving Seat through a Personalized, Customer-Centric Approach

Cloud Computing for Affordable Medicines

Manoj Shah, VP, IT and Business Support, Amneal Pharmaceuticals (NYSE: AMRX)

Molecular Devices Challenges and Trends in the Sythetic Biology Space

Dan O’Connor, VP Drug Discovery, Western Markets, Molecular Devices

Science-Led Data Collection: Because a Clinical Trial is Only as Good as Its Data

Lindsay Hughes, PhD, MS – Director, eCOA Science & Consulting and Jowita Marszewska, PhD – eCOA Scientific Advisor at Clario

Accelerating Early-Stage Drug Development

Safwan Kezbor, M.D. Medical Director, Clinical Development, Shionogi Inc.

Medical Affairs Takes Centre Stage

Dr Sarah Tregenza PhD BSc(Hons), APAC Oncology Medical Affairs Director, Pierre Fabre

The Role Of Patient Reported Outcomes To Support Reimbursement And Market Access In Major European Countries And The Us

Lothar Tremmel, Vice President, QCSR at CSL Behring

Accelerating Drug Development Of Novel Targeted Therapies Through Histology-Agnostic Oncology Clinical Trials

Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker at Zai Lab

Growing Demand For More Specialized Services Specialized Services: A New Paradigm In Therapeutics

Brian Fry, Director, Global Cell Therapy, Charles River Laboratories

Could A Syndromic Diagnosis Overcome Challenges Faced By Antimicrobial Stewardship Programs During The Covid-19 Pandemic?

Sonia N. Rao, PharmD, BCIDP and Davide Manissero, MD, MRCPCH, MSc, DTM&H, QIAGEN

Immunotherapy: shaping a new era of patient centric care

Danie du Plessis, Executive VP Medical Affairs, Kyowa Kirin

The Cancer Immunotherapy Treatment Paradigm

Charles Drake, M.D., Ph.D., Vice President, Immuno-Oncology, Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson

Understanding the Importance of Building Rapport to Enhance Patient Experience in Telehealth

Toufic Kachaamy, Medical Director of Gastroenterology, Cancer Treatment Centers of America

Leveraging Technology to Boost Immunotherapy

Li Chen, Vice President & General Manager, Biologics, West Pharmaceutical Services, Inc.

The World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma Industry

Paul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations Astellas Pharma US, Inc.

The World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma Industry

Paul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations Astellas Pharma US, Inc.

Successful Digital Transformation

Shubha Chaudhari, Head of GSK Clinical Technology Solutions

Innovation Vs Validation in Early Drug Discovery

Carlos Pedraza, PhD. Director of CNS Biology at Alkermes

A proposal for a new strategy in oncology clinical development

Stefano Ferrara, Director, Clinical Science, BeiGene

Specials

Antibodies: The Building Blocks of Cures

The Future of Life Sciences Industry

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Re-imagining Learning in a Post-Pandemic World

How Charles River Labs is Re-Imaging Digital Transformation with Design Thinking

How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

The Science Behind Addiction and Why it Matters to Employers

Antibodies: The Building Blocks of Cures

The Future of Life Sciences Industry

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Re-imagining Learning in a Post-Pandemic World

How Charles River Labs is Re-Imaging Digital Transformation with Design Thinking

How can Manufacturing Companies Keep Pace with the Shifting Trends of Oncology Drug Development

The Science Behind Addiction and Why it Matters to Employers

Put your Frontline Teams in the Driving Seat through a Personalized, Customer-Centric Approach

Cloud Computing for Affordable Medicines

Molecular Devices Challenges and Trends in the Sythetic Biology Space

Science-Led Data Collection: Because a Clinical Trial is Only as Good as Its Data

Accelerating Early-Stage Drug Development

Medical Affairs Takes Centre Stage

The Role Of Patient Reported Outcomes To Support Reimbursement And Market Access In Major European Countries And The Us

Accelerating Drug Development Of Novel Targeted Therapies Through Histology-Agnostic Oncology Clinical Trials

Growing Demand For More Specialized Services Specialized Services: A New Paradigm In Therapeutics

Could A Syndromic Diagnosis Overcome Challenges Faced By Antimicrobial Stewardship Programs During The Covid-19 Pandemic?

Immunotherapy: shaping a new era of patient centric care

The Cancer Immunotherapy Treatment Paradigm

Understanding the Importance of Building Rapport to Enhance Patient Experience in Telehealth

Leveraging Technology to Boost Immunotherapy

The World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma Industry

The World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma Industry

Successful Digital Transformation

Innovation Vs Validation in Early Drug Discovery

A proposal for a new strategy in oncology clinical development